Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check27 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.5%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check41 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry labeled v3.7.0 was added to the study history, and the prior revision v3.6.6 was removed, updating the version history displayed on the page.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history shows a new revision entry updating the page to version v3.6.6, signaling a small system update to the record history interface.SummaryDifference0.1%

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.